跳至主要内容
临床试验/NCT02174783
NCT02174783终止不适用

The Safety and Efficacy of Mediterranean Diet and Protein-Sparing Modified Diet on Obesity and Metabolic Syndrome in Liver Transplant Recipients: A Randomized Clinical Trial

The Cleveland Clinic2 个研究点 分布在 1 个国家目标入组 25 人开始时间: 2014年6月最近更新:
适应症

试验速览

阶段
不适用
状态
终止
入组人数
25
试验地点
2
主要终点
Weight loss

研究概览

简要总结

Many metabolic complications can develop after liver transplant including: diabetes, high blood pressure, obesity, heart attacks and stroke. The goal of this study is to look at the safety and effect of 2 well known and established diet regimens on the people who had a prior liver transplant and investigate whether it helps with the control of these comorbidities.

详细描述

The Mediterranean diet has been shown to be effective in improving hepatic steatosis, insulin sensitivity, diabetes control and reducing cardiovascular risk in adult patients, but there is no data available for patients who underwent liver transplant. The protein-sparing modified fast (PSMF) diet has been used for years at the Cleveland Clinic to treat adult patients with obesity-related medical problems, but its safety and efficacy has not been established in liver transplant recipients.

研究设计

研究类型
Interventional
分配方式
Randomized
干预模型
Parallel
主要目的
Treatment
盲法
None

入排标准

年龄范围
18 Years 至 —(Adult, Older Adult)
性别
All
接受健康志愿者

入选标准

  • Adult patients > 18 years old who had a successful liver transplant at least 1 year prior to enrollment who also have a BMI>30 with previous failed attempts at weight loss via conventional methods. In addition to one of the following:
  • Triglyceride (TG)>150 mg/dl or specific treatment for this lipid abnormality
  • HDL <40 mg/dl in females and <50 mg/dl in males or specific treatment of this lipid abnormality
  • Systolic BP >130 or diastolic BP >85 mm Hg or treatment for previously diagnosed hypertension
  • Fasting plasma glucose >100 mg/dl or previously diagnosed type 12 diabetes

排除标准

  • Significant behavioral issues that would interfere with compliance
  • Lack of readiness to change (pre-contemplation, contemplation or preparation stages)
  • Previous bariatric surgery
  • Pregnant or planning to become pregnant
  • History of a documented eating disorder (e.g. bulimia)
  • History of kidney stones

结局指标

主要结局

Weight loss

时间窗: 6 months

次要结局

  • Change in blood pressure compared to baseline(6 months)
  • Change in triglyceride compared to baseline(6 months)
  • Change in Hb A1c compared to baseline(6 months)
  • Change in HDL and LDL compared to baseline(6 months)
  • Number of Participants with Serious and Non-Serious Adverse Events(6 months)

研究者

申办方类型
Other
责任方
Sponsor

研究点 (2)

Loading locations...

相似试验